000			02995cam a2200349 a 4500
003			EG-GiCUC
005			20250223031912.0
008			180109s2017 ua dho f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.24.03.Ph.D.2017.Sh.E
100	0		_aShimaa Abdelalim Mahmmoud Essa
245	1	0	_aEfficacy of combined use of low intensity laser therapy and ultraviolet radiation in the treatment of relapsing-remitting multiple sclerosis patients / _cShimaa Abdelalim Mahmmoud Essa ; Supervised Yousry Mahmoud Mostafa , Shereen Mohamed Fathi Sheir , Ayatullah Farouk Ahmed
246	1	5	_aفعالية الإستخدام المشترك لليزر منخفض الشدة والأشعة فوق البنفسجية فى علاج مرضى التصلب المتعدد الإنتكاسى- الإنحصاري
260			_aCairo : _bShimaa Abdelalim Mahmmoud Essa , _c2017
300			_a141 P. : _bcharts , facsimiles , photographs ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - National Institute of Laser Enhanced Sciences - Department of Laser Applications in Medicine and Biology
520			_aBackground: Multiple sclerosis is an Inflammatory and neurodegenerative disease of the central nervous system of unknown reason or definite cure. Purpose: Proposing safe alternative therapies for the early management of multiple sclerosis. Study Design: Repeated measures randomized control trial. Materials and methods: 24 patients with relapsing-remitting multiple Sclerosis, from both sexes completed the study, age 25-45 years; randomly assigned into four groups. Seven patients in the control group (1); received monthly IV infusion of (1g) Solu-Medrol therapy for multiple sclerosis. Six Patients in group (2) received Solu-Medrol plus low intensity laser therapy LILT 850 nm. Six patients in group (3) received Solu-Medrol plus broad band ultraviolet B radiation BB-UVBR (280-320 nm). Five patients in group (4) received Solu-Medrol, scanner LILT and BB-UVBR; all three groups received sessions 3 days/week for 12 sessions. Expanded disability status Scale (EDSS), Fatigue severity scale (FSS), visual evoked potential (VEP), H-reflex latency, and H/M Ratio were assessed pre-treatment, post treatment, 3 months follow up. Results: Statistically significant reduction of fatigue severity FSS was recorded between the four groups post treatment (p=.013) in favor of group (4) and highly significant one (p=.005) at follow up in favor of the group (3)
530			_aIssued also as CD
653		4	_aBroad Band Ultraviolet B Radiation
653		4	_aMultiple Sclerosis
653		4	_aPhototherapy
700	0		_aAyatullah Farouk Ahmed , _eSupervisor
700	0		_aShereen Mohamed Fathi Sheir , _eSupervisor
700	0		_aYousry Mahmoud Mostafa , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aShimaa _eCataloger
942			_2ddc _cTH
999			_c64503 _d64503